Serum cholesterol and statin use predict virological response to peginterferon and ribavirin therapy.
Harrison SA, Rossaro L, Hu KQ, Patel K, Tillmann H, Dhaliwal S, Torres DM, Koury K, Goteti VS, Noviello S, Brass CA, Albrecht JK, McHutchison JG, Sulkowski MS.
Harrison SA, et al. Among authors: torres dm.
Hepatology. 2010 Sep;52(3):864-74. doi: 10.1002/hep.23787.
Hepatology. 2010.
PMID: 20568303
Clinical Trial.